(4-bromomethyl-phenyl)(3-chloro-phenyl)methanone | 945657-22-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-bromomethyl-phenyl)(3-chloro-phenyl)methanone
• 英文别名: [4-(Bromomethyl)phenyl](3-chlorophenyl)methanone；[4-(bromomethyl)phenyl]-(3-chlorophenyl)methanone
• CAS: 945657-22-7
• 化学式: C₁₄H₁₀BrClO
• 分子量: 309.59
• InChiKey: BIOFUZCTWISNOB-UHFFFAOYSA-N

物化性质

• 沸点：
  416.6±35.0 °C(Predicted)
• 密度：
  1.481±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (4-bromomethyl-phenyl)(3-chloro-phenyl)methanone 在 sodium tetrahydroborate 、 三乙胺 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 3.0h， 生成 (+/-)-(3-chlorophenyl)[4-(pyrrolidin-1-ylmethyl)phenyl]methanol
  参考文献：
  名称：

  Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling

  摘要：

  The design, synthesis, and antiplasmodial activity of antimalarial heterodimers based on the 1,4-bis(3-aminopropyl)piperazine linker is reported. In this series key structural elements derived from quinoline antimalarials were coupled to fragments capable of coordinating metal ions. Biological evaluation included determination of activity against chloroquine-sensitive and chloroquine-resistant Plasmodiunifaleiparum strains. Some of the novel compounds presented high activity in vitro against chloroquine-resistant strains, more potent than chloroquine and clotrimazole. Computational studies revealed that the activity is likely due to the ability of the compounds to assume a multisite iron coordinating geometry. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.04.077
• 作为产物：
  描述：

  对溴甲苯 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 、 magnesium 作用下， 以 四氢呋喃 、 四氯化碳 为溶剂， 反应 8.0h， 生成 (4-bromomethyl-phenyl)(3-chloro-phenyl)methanone
  参考文献：
  名称：

  WO2008/101891

  摘要：

  公开号：

文献信息

• Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure–Activity Relationships, in Vivo Studies, and Preliminary Toxicity Profiling
  作者：Sandra Gemma、Caterina Camodeca、Salvatore Sanna Coccone、Bhupendra P. Joshi、Matteo Bernetti、Vittoria Moretti、Simone Brogi、Maria Cruz Bonache de Marcos、Luisa Savini、Donatella Taramelli、Nicoletta Basilico、Silvia Parapini、Matthias Rottmann、Reto Brun、Stefania Lamponi、Silvio Caccia、Giovanna Guiso、Robert L. Summers、Rowena E. Martin、Simona Saponara、Beatrice Gorelli、Ettore Novellino、Giuseppe Campiani、Stefania Butini

  DOI：10.1021/jm300802s

  日期：2012.8.9

  the treatment of infections. We recently reported the development of a novel antimalarial drug that combines the 4-aminoquinoline pharmacophore of chloroquine with that of clotrimazole-based antimalarials. Here we describe the optimization of this class of hybrid drug through in-depth structure–activity relationship studies. Antiplasmodial properties and mode of action were characterized in vitro and

  尽管最近在抗击疟疾方面取得了进展，但耐药性寄生虫的出现和扩散仍然是感染治疗的严重障碍。我们最近报道了一种新型抗疟药的开发，该药结合了氯喹的4-氨基喹啉药效基团和基于克霉唑的抗疟药。在这里，我们通过深入的结构-活性关系研究来描述这类杂合药物的优化。在体外和体内表征了抗疟原虫的性质和作用方式，并在非洲爪蟾卵母细胞表达系统中研究了与寄生虫的“氯喹抗性转运蛋白”的相互作用。这些测试表明哌嗪衍生物4b和4d可能适合与氯喹共同使用，以抵抗耐氯喹的寄生虫。在计算机上测定了细胞色素P450代谢药物的潜力，并测试了先导化合物的毒性和致突变性。在小鼠中进行的初步药代动力学分析表明，化合物4b具有最佳的半衰期。
• NOVEL 4-AMINO-QUINOLINE DERIVATIVES USEFUL AS ANTI-MALARIA DRUGS
  申请人：Campiani Giuseppe

  公开号：US20100093726A1

  公开（公告）日：2010-04-15

  The present invention relates to clotrimazole/quinoline hybrids useful as active ingredients of anti-malaria drugs. The compounds show a remarkable in vitro biological activity especially against the chloroquine-resistant Plasmodium falciparum strains and in vivo activity against P. berghei.

  本发明涉及克霉唑/喹啉杂合物，可作为抗疟疾药物的活性成分。这些化合物在体外显示出显著的生物活性，特别是对氯喹耐药恶性疟原虫株的活性，以及对伯氏恶性疟原虫的体内活性。
• Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity
  作者：Nicola Relitti、Stefano Federico、Luca Pozzetti、Stefania Butini、Stefania Lamponi、Donatella Taramelli、Sarah D’Alessandro、Rowena E. Martin、Sarah H. Shafik、Robert L. Summers、Simone K. Babij、Annette Habluetzel、Sofia Tapanelli、Reto Caldelari、Sandra Gemma、Giuseppe Campiani

  DOI：10.1016/j.ejmech.2021.113227

  日期：2021.4
• Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold:  Exploring an Innovative Pharmacophore
  作者：Sandra Gemma、Giuseppe Campiani、Stefania Butini、Gagan Kukreja、Bhupendra P. Joshi、Marco Persico、Bruno Catalanotti、Ettore Novellino、Ernesto Fattorusso、Vito Nacci、Luisa Savini、Donatella Taramelli、Nicoletta Basilico、Giulia Morace、Vanessa Yardley、Caterina Fattorusso

  DOI：10.1021/jm061429p

  日期：2007.2.1

  Identification of new molecular scaffolds structurally unrelated to known antimalarials may represent a valid strategy to overcome resistance of P. falciparum (Pf) to currently available drugs. We describe herein the investigation of a new polycyclic pharmacophore, related to clotrimazole, to develop innovative antimalarial agents. This study allowed us to discover compounds characterized by a high in vitro potency, particularly against Pf CQ-resistant strains selectively targeting free heme, which are easy to synthesize by low-cost synthetic strategies.
• Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, and Biological and Structure–Activity Relationship Studies
  作者：Sandra Gemma、Giuseppe Campiani、Stefania Butini、Gagan Kukreja、Salvatore Sanna Coccone、Bhupendra P. Joshi、Marco Persico、Vito Nacci、Isabella Fiorini、Ettore Novellino、Ernesto Fattorusso、Orazio Taglialatela-Scafati、Luisa Savini、Donatella Taramelli、Nicoletta Basilico、Silvia Parapini、Giulia Morace、Vanessa Yardley、Simon Croft、Massimiliano Coletta、Stefano Marini、Caterina Fattorusso

  DOI：10.1021/jm701247k

  日期：2008.3.13

  We describe herein the design, synthesis, biological evaluation, and structure-activity relationship (SAR) studies of an innovative class of antimalarial agents based on a polyaromatic pharmacophore structurally related to clotrimazole and easy to synthesize by low-cost synthetic procedures. SAR studies delineated a number of structural features able to modulate the in vitro and in vivo antimalarial activity. A selected set of antimalarials was further biologically investigated and displayed low in vitro toxicity on a panel of human and murine cell lines. In vitro, the novel compounds proved to be selective for free heme, as demonstrated in the beta-hematin inhibitory activity assay, and did not show inhibitory activity against 14-alpha-lanosterol demethylase (a fungal P450 cytochrome). Compounds 2, 4e, and 4n exhibited in vivo activity against P. chabaudi after oral administration and thus represent promising antimalarial agents for further preclinical development.